Just's botanischer jahresbericht. Systematisch geordnetes repertorium der botanischen literatur aller länder.

Jahrg. 48, Abt. 2 (1920)

The genus Bostryx in central western Argentina: anatomical and distributional description of four of its southernmost species (Gastropoda, Bulimulidae)

ABSTRACT The genus Bostryx Troschel, 1847 is endemic to South America, extending from Ecuador to Chile and Argentina. The southernmost Argentinian species of the genus that inhabit San Luis, San Juan and Mendoza provinces, specially the pre-Andes, Andes and Sierras Pampeanas mountain ranges, were examined. This is the first time the anatomy of Bostryx pastorei (Holmberg, 1912), Bostryx reedi (Parodiz, 1947) and Bostryx strobeli (Parodiz, 1956) has been described.Bostryx cordillerae (Strobel, 1874) is re-described regarding shell and anatomy due to new morphological data. The main differences among the species examined are based on shell characters. The distribution ofBostryx mendozanus (Strobel, 1874) and Bostryx cuyanus (Pfeiffer, 1867), other species found in this region, was also discussed.

Proceedings of the American Academy of Arts and Sciences.

v. 10, new ser. v. 2 (1874-1875)

The Canadian entomologist.

v. 6 (1874)

Bulletin de la Société royale de botanique de Belgique.

t. 13 (1874)

Recherches pour servir a l'histoire naturelle des végétaux infé rieurs / par J. de Seynes.

3

Recherches pour servir a l'histoire naturelle des végétaux infé rieurs / par J. de Seynes.

1-2

Just's botanischer jahresbericht. Systematisch geordnetes repertorium der botanischen literatur aller länder.

Jahrg. 49, Abt. 1 (1921)

Just's botanischer jahresbericht. Systematisch geordnetes repertorium der botanischen literatur aller länder.

Jahrg. 46, Abt. 1 (1918)

Transactions of the California State Agricultural Society.

1874

Econometrics

This is a project to develop a document for teaching graduate econometrics that is "open source", specifically, licensed as GNU GPL. That is, anyone can access the document in editable form, and can modify it, as long as they make their modifications available. This allows for personalization, as well as a simple way to make contributions and error corrections. The hope is that people preparing to teach econometrics for the first time might find it useful, and eventually be motivated to contribute back to the project. The central document is something between a set of lecture notes and a text book. It's not as terse as lecture notes, but not as complete or well-referenced as a text book. Of course, the document is constantly evolving, and you are welcome to modify it as you like. The document contains (at least when viewed in HTML or PDF form) hyperlinks to example programs written using the GNU/Octave language. The document itself is written using the LyX word processor. LyX documents can be exported as LaTeX, so the system is quite portable.

PFO closure vs. medical therapy in cryptogenic stroke or transient ischemic attack: A systematic review and meta-analysis.

BACKGROUND/OBJECTIVES: This study aims to assess whether patent foramen ovale (PFO) closure is superior to medical therapy in preventing recurrence of cryptogenic ischemic stroke or transient ischemic attack (TIA). METHODS: We searched PubMed for randomized trials which compared PFO closure with medical therapy in cryptogenic stroke/TIA using the items: "stroke or cerebrovascular accident or TIA" and "patent foramen ovale or paradoxical embolism" and "trial or study". RESULTS: Among 650 potentially eligible articles, 3 were included including 2303 patients. There was no statistically significant difference between PFO-closure and medical therapy in ischemic stroke recurrence (1.91% vs. 2.94% respectively, OR: 0.64, 95%CI: 0.37-1.10), TIA (2.08% vs. 2.42% respectively, OR: 0.87, 95%CI: 0.50-1.51) and death (0.60% vs. 0.86% respectively, OR: 0.71, 95%CI: 0.28-1.82). In subgroup analysis, there was significant reduction of ischemic strokes in the AMPLATZER PFO Occluder arm vs. medical therapy (1.4% vs. 3.04% respectively, OR: 0.46, 95%CI: 0.21-0.98, relative-risk-reduction: 53.2%, absolute-risk-reduction: 1.6%, number-needed-to-treat: 61.8) but not in the STARFlex device (2.7% vs. 2.8% with medical therapy, OR: 0.93, 95%CI: 0.45-2.11). Compared to medical therapy, the number of patients with new-onset atrial fibrillation (AF) was similar in the AMPLATZER PFO Occluder arm (0.72% vs. 1.28% respectively, OR: 1.81, 95%CI: 0.60-5.42) but higher in the STARFlex device (0.64% vs. 5.14% respectively, OR: 8.30, 95%CI: 2.47-27.84). CONCLUSIONS: This meta-analysis does not support PFO closure for secondary prevention with unselected devices in cryptogenic stroke/TIA. In subgroup analysis, selected closure devices may be superior to medical therapy without increasing the risk of new-onset AF, however. This observation should be confirmed in further trials using inclusion criteria for patients with high likelihood of PFO-related stroke recurrence.